The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer

NCT03985891 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colonic Neoplasms
Chemotherapy Effect

Interventions

DRUG: Anti-PD-1 Monoclonal Antibody JS001
DRUG: Chemotherapy

Sponsor

Xiangya Hospital of Central South University